1201817007: Benzoxonium (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Benzoxonium

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Quaternary ammonium compound\Benzoxonium

\Organic compound\Organic nitrogen compound\Quaternary ammonium compound\Benzoxonium

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4945137018 Benzoxonium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4945138011 Benzoxonium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Benzoxonium	Is a	Quaternary ammonium compound	true	Inferred relationship	Some
Benzoxonium	Is a	Anti-infective agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing benzoxonium and lidocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Benzoxonium	Inferred relationship	Some	1
Benzoxonium and lidocaine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Benzoxonium	Inferred relationship	Some	1
Product containing benzoxonium and lidocaine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Benzoxonium	Inferred relationship	Some	1
Benzoxonium and lidocaine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Benzoxonium	Inferred relationship	Some	1
Benzoxonium chloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Benzoxonium	Inferred relationship	Some

This concept is not in any reference sets